Precision Oncology Today
Generative AI is a new and rapidly emerging form of artificial intelligence that has the potential to revolutionize precision medicine by improving diagnosis, treatment, and drug discovery.
Nanotechnology opens the door to a range of unique methods for sensing cancer biomarkers in body fluids, thanks to the unusual properties and capabilities of nanoscale systems. Going small promises big gains in diagnosing and tracking a wide range of tumors.
Trending on Inside Precision Medicine
The newly launched Seattle Hub for Synthetic Biology will build new technologies to record the history of cells over time.
A 3D printing technique that uses sound waves could one day be used to build and repair tissues from within the body, paving the way towards minimally invasive medicine.
Researchers at Case Western Reserve University say that a class of diabetes drugs used to treat type 2 diabetes may reduce the risk of the development of colorectal cancer (CRC).